2018
DOI: 10.1007/s00384-018-2996-8
|View full text |Cite
|
Sign up to set email alerts
|

Study protocol for a multicenter prospective controlled and randomized trial of transanal total mesorectal excision versus laparoscopic low anterior resection in rectal cancer

Abstract: ClinicalTrials.gov Identifier: NCT02550769. Registration no. Ethical and Clinical Research Committee, Parc Taulí University Hospital: ID 2014/064.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 31 publications
0
3
0
Order By: Relevance
“…Studies comparing transanal TME to other approaches of rectal cancer treatment need to be conducted to better assess the potential benefit in cancerspecific outcomes and patients' overall wellbeing. Two future randomized studies may help clarify these questions [55,56] .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Studies comparing transanal TME to other approaches of rectal cancer treatment need to be conducted to better assess the potential benefit in cancerspecific outcomes and patients' overall wellbeing. Two future randomized studies may help clarify these questions [55,56] .…”
Section: Discussionmentioning
confidence: 99%
“…Although the primary endpoint will be the circumferential resection margin, the secondary endpoints will include disease-free survival, overall survival, and quality of life. Serra-Aracil et al [56] published a protocol to study a combined TaTME combined with laparoscopy to evaluate if there would be a lower conversion rate than laparoscopic low anterior resection, and potentially improve patient recovery and overall morbidity, and quality of life measures. Quality of life measures will be examined preoperatively and 6 months after the closure of protective ileostomy using the EORTC QLQ-C30, QLQ-CR29, and LARS score.…”
Section: Tatmementioning
confidence: 99%
“…The exclusion criteria are open surgery or conversion to open surgery (defined as any intervention that requires removal of laparoscopic material and conversion to traditional open surgery [9]); administration of epidural anaesthesia or ASA IV; preoperative diagnosis of urinary tract infections (more than three episodes/year documented by urine culture, or two urinary tract infections in the last 6 months); moderate–severe prostate clinical symptoms (IPSS > 20); in men, the presence of positive urine culture in preoperative tests; in women, clinical symptoms of urine infection with positive urine culture. Previous history of AUR, the presence of a permanent bladder or ureteral catheter and intermittent self‐catheterization will also be grounds for exclusion.…”
Section: Methodsmentioning
confidence: 99%